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Summary: A simple and rapid gas-liquid Chromatographie method for the determination of valproic acid in serum is
described. Valproic acid is extracted from acidified serum into chloroform and analyzed by gas-liquid chromatography
using an FFAP column.
The sensitivity of the method is 5 μπιοΐ/l and the within-run and day-to-day precisions (CV) are 4.5% or better.
Analytical recovery is estimated to exceed 98% and no interference from other drugs or constituents of serum has
been observed.
The method was used to study the half-life of valproic acid in five healthy persons receiving a single oral dose of the
drug, and the technique is well adapted to the routine monitoring of epileptic patients. In routine analysis, the deter-
mination of 50 serum samples may be performed by one technician during a normal working day.
Schnelle und einfache gaschromatographische Bestimmung von Valproins ure (a-Propylvalerians ure) im Serum
Zusammenfassung: Eine einfache und schnelle gaschromatographische Methode zur Bestimmung von Valproins ure
im Serum wird beschrieben. Valproins ure wird aus anges uertem Serum in Chloroform extrahiert und gaschromato-
graphisch mit einer FF AP-S ule analysiert. Die Empfindlichkeit der Methode betr gt 5 μιηοΐ/ΐ, die Pr zision in der
Serie und von Tag zu Tag 4,5% oder weniger. Die Wiederfindung betr gt mehr als 98%; St rungen durch andere
Arzneimittel oder Serumbestandteile wurden nicht beobachtet. Die Methode wurde zur Untersuchung der Halbwerts-
zeit von Valproins ure bei 5 gesunden Probanden nach einmaliger oraler Gabe eingesetzt und ist geeignet zur Rou-
tinekontrolle von Epileptikern. Von einer Mitarbeiterin kann an einem normalen Werktag die Bestimmung in 50 Se-
rumproben durchgef hrt werden.
introduction This report describes a simple, rapid, and accurate gas-
Sodium valproate {α-propyl-valeric acid) is widely U(luid Chromatographie determination of valproic acid
used in the treatment of convulsive disorders. The quan- "W* an FFAP column, and caproic acid as the mternal
titative determination of the drug is important both standard' **ts of *» work have been P^'ed as a
for monitoring and optimizing blood levels of patients c°ngress abstract (10).
receiving therapeutic doses, as well as the study of the
pharmac kinetic properties. Several gas-liquid Chromato-
graphie methods are available for measuring the _ _ . ·
circulating concentrations of valproic acid (1 -9). Materials and Metnods
Although the methods appear to be specific and aceu^ Reagents
rate, they tend to be tedious and lengthy, and thus Chloroform (Merck No. 2445, E. Merck, D-6100 Darmstadt,
not suitable for the rapid manual analysis of multiple F.R.G.) was distilled before use.
samples. Hydrochloric acid (Merck No. 319) 6 mo 1/1 aqueous.
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Internal standard solution: caproicacid (Fluka No. 21529,
Fluka AG, CH-9470 Buchs, Switzerland) 1 g/1 in absolute
ethanol.
Stock valproic acid standard solution, 0.100 mol/1: dissolve
1.442 g of α-propyl-valeric acid (kindly supplied by Orion
Pharmaceutical Co., PL 19, SF-00101 Helsinki, Finland) in
100 ml of absolute ethanol.
librking valproic acid standard, 1000 μηιοΐ/ΐ, 500 μηιοΐ/ΐ and
250 μπιοΐ/ΐ in pooled, drug free serum. Store in aliquots at
-20°C.
Other drugs: tripropylacetamide (as a gift from Orion Pharma^
ceutical Co.), 1 g/1 and dipropylacetamide (generous gift from
Labaz, 39. Avenue Pierre 1. De Serbie, F-75008 Paris, France),
1 g/1, were dissolved in acetone (Merck No. 14). Ethosuximide
(Orion Pharmaceutical Co.), 1 g/1, was dissolved in ethanol.
Gas Chromatographie conditions
A Carlo Erba 2301 AG gas Chromatograph was used with a
flame ionization detector fitted with a l m X 3 mm i. d. glass
column. The column contained a liquid phase of 5% FFAP
(Varian Aerograph, Walnut Creek, Calif., U.S.A.) on Chromo-
sorb G AW DMCS 80/100 mesh (Applied Science Laboratories
Inc., State College, PA. 16801, U.S.A.). The oven and injector
temperatures were 190 °C and 225 °C, respectively, and nitrogen
was used as the carrier gas. The gas Chromatograph was connected
to a Varian Aerograph CDS 220/240 chromatography data
system.
Procedure
To a serum sample (0.5 ml) in a stoppered, narrow pointed
centrifuge tube is added 0.05 ml of internal standard solution,
and 0.05 ml of hydrochloric acid (6 mol/1) to make the solution
acidic. After mixing, the sample is extracted with 1.0 ml of
chloroform by mixing for 30 seconds on a Vortex mixer,
followed by centrifugation at 2000 g for 5 min. The upper
water layer is removed and the clear chloroform phase trans^
ferred into a stoppered glass tube, lifting the protein and lipid
layers with a Pasteur pipette. One microliter of this chloroform
solution is injected into the gas Chromatograph. A calibration
curve was prepared by subjecting working valproic acid standards '
to the above procedure. Peak area ratios of valproic acid and
the internal standard (by chromatography data processor) were
plotted as a function of valproic acid concentration. It was also
verified that the peak height ratio calculation gave sufficient
accuracy. The relationship between peak height ratio and con-
centration was linear at least up to 2 mmol/1.
Results and Discussion
Specificity
Representative chiomatograms of serum specimens
extracted according to our procedure are presented in
figure 1. Chromatogram (a) is a pattern typical of the
serum of a normal individual not receiving drugs.
Chromatogram (b) is obtained from the serum of an
individual receiving sodium valproate. The concentra-
tion of the drug in this sample was 380 μπιοΐ/ΐ. No
interfering peaks in the same region of either drug or
internal standard have been encountered from constit-
uents of lipemic or hemolytic sera. Dipropylacetamide,
tripropylacetamide and ethosuximide do extract and
Chromatograph under these conditions; moreover, they
have retention times of about 7,10 and 16 min, respect-
ively, compared to 3.5 min for valproic acid. In addi-
tion, no other interference has been found in the
analysis of nearly 2000 serum samples from patients
taking anticonvulsant drugs.
H
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Fig. 1. Typical gas-chromatogram of: a) Serum blank (normal
individual not receiving drugs), b) Serum from a patient
treated with sodium valproate.
Sensitivity
In sensitivity studies a drug free serum sample was
spiked with valproic acid to a concentration of 5 μιηοΐ/ΐ
and processed as described above. The mean peak area
ratio was found to be 0.0089 (N = 6, CV = 10.8%)
indicating that 5 μηιοΐ/ΐ of valproic acid in serum can be
determined with acceptable precision in 0.5 ml serum
samples.
Recovery
Absolute recovery of valproic acid from serum was
studied by adding known quantities of valproic acid
to a serum known to be drug-free. These samples were
processed as described above. A second (non-extracted)
set of standards was prepared in chloroform at the same
concentration. One microliter of each sample was
chromatographed. Absolute recovery of valproic acid
from serum was calculated by comparision of the ratio
of the peak heights of the extracted serum samples with
those of the non-extracted standards. The recovery of
valproic acid determined in this way was 99.7% at a
concentration of 1 mmol/1, and 100.4% at concentra-
tion of 2 mmol/1.
The relative recovery of valproic acid was also deter-
mined. Known amounts of valproic acid in ethanol were
added to pooled patient serum to achieve the concentra-
tions shown in table 1. The samples were processed as
Tab. 1. Relative recovery of valproic acid added to pooled
patient sera (N = 5).
Initial Calculated Measured
concentration concentration concentration
after addition after addition
Oimoi/1) (μπιοΐ/l) (μηιοΐ/ΐ)
Recovery
302
302
602
902
598
897
98.7
99.2
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described above. At least five samples were analyzed at
both concentrations. Relative recoveries are shown in
table 1.
Precision
Within-run precision was evaluated by processing aliquots
of pooled patient sera containing valproic acid in the
concentrations shown in table 2. Day-to-day precision
was calculated from data obtained on samples analyzed
over 6 months.
Tab. 2. Precision of assay for valproic acid in serum.
Mean (μπιοΐ/ΐ)
SD (Mmol/1)
CV(%)
N
Within-run
146.3 439.2 759.1
4.56 9.93 15.21
3.1 2.3 2.0
20 20 20
Day-to-day
354.5
17.34
4.5
25
Clinical studies
Examination of five healthy volunteers showed that after
an oral dose of 600 mg, sodium valproate is rapidly
absorbed, reaching peak levels (436 + 22 μτηρί/ΐ; mean
± standard error of mean, Ν = 5) in the serum about
one hour after ingestion. Serum levels of the drug then
fell rapidly over 8 hours and more slowly after this
time. The drug was still present 24 hours after a single
dose. The half-life of valproic acid was about 10 hours
(8—10 hours), which is in good agreement with the
times reported in the literature (11—14).
In a study of 950 serum samples from epileptic patients
receiving sodium valproate, the highest serum level was
1.1 mmol/1, 70% of the results falling in the range
210-700 jumol/1. This compares well with the results
of others (1,15).
Conclusion
For those laboratories in which a gas Chromatograph
with a flame ionization detector is available, the present
method is fast and simple, while retaining excellent
accuracy and precision. Complete analysis time for an
urgent determination is 30 minutes, while in routine
analysis the determination of 50 serum samples may be
performed by one technician in a normal working day.
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